Leclanche Aktie 11030311 / CH0110303119
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
25.02.2026 07:00:10
|
Leclanché Appoints Jens Emrich as Chief Financial Officer
|
Leclanché SA / Key word(s): Personnel Ad hoc announcement pursuant to Art. 53 LR
YVERDON-LES-BAINS, Switzerland, 25th of February, 2026 – Leclanché SA (SIX: LECN) announces the appointment of Jens Emrich as Chief Financial Officer, effective 1st March 2026. Jens Emrich brings more than 25 years of international finance leadership experience across industrial and energy-related sectors. Most recently, he served as Director Financial Decision Support & Insight EMEA (Regional CFO) at Li-Cycle Europe AG, where he established and led the regional finance organisation for the NYSE-listed lithium-ion battery recycling company. In this role, he oversaw financial governance, statutory reporting, cash management and capex deployment across multiple European jurisdictions and supported the scale-up of the company’s German operations. Previously, he held senior finance leadership positions at Key Surgical Europe (part of Steris plc), LBNUTS AG and Lorenz Snack-World, where he led financial transformation, integration and restructuring initiatives. Pierre Blanc, CEO of Leclanché Group, commented: “Jens brings strong experience in financial transformation, industrial scale-up and international governance. His expertise will be instrumental as we continue to strengthen our financial structure and support the company’s next phase of development”. Further information on Mr. Emrich’s background will be available on the Company’s website.
# # #
About Leclanché Leclanché is a world leading provider of low-carbon footprint energy storage solutions based on lithium-ion cell technology. Established in 1909 in Yverdon-les-Bains, Switzerland, Leclanché’s history and heritage is rooted in battery and energy storage innovation. The company’s Swiss culture for precision and quality, together with its production facilities in Germany, make Leclanché the partner of choice for companies seeking the very best in battery performance and who are pioneering positive changes in how energy is produced, distributed and consumed around the world. Leclanché is organised into three business units: energy storage solutions, e-Mobility solutions and specialty battery systems. The company currently employs over 350 people with representative offices in eight countries around the world. Leclanché is listed on the Swiss Stock Exchange (SIX: LECN). SIX Swiss Exchange : ticker symbol LECN | ISIN CH 011 030 311 9
Disclaimer This press release contains certain forward-looking statements relating to Leclanché's business, which can be identified by terminology such as "strategic", "proposes", "to introduce", "will", "planned", "expected", "commitment", "expects", "set", "preparing", "plans", "estimates", "aims", "would", "potential", "awaiting", "estimated", "proposal", or similar expressions, or by expressed or implied discussions regarding the ramp up of Leclanché's production capacity, potential applications for existing products, or regarding potential future revenues from any such products, or potential future sales or earnings of Leclanché or any of its business units. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of Leclanché regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Leclanché's products will achieve any particular revenue levels. Nor can there be any guarantee that Leclanché, or any of the business units, will achieve any particular financial results.
Media contacts: End of Inside Information |
| Language: | English |
| Company: | Leclanché SA |
| Av. des Sports 42 | |
| 1400 Yverdon-les-Bains | |
| Switzerland | |
| Phone: | +41 (24) 424 65-00 |
| Fax: | +41 (24) 424 65-20 |
| E-mail: | investors@leclanche.com |
| Internet: | www.leclanche.com |
| ISIN: | CH0110303119, CH0016271550 |
| Valor: | A1CUUB, 812950 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2281064 |
| End of Announcement | EQS News Service |
|
|
2281064 25-Feb-2026 CET/CEST
Nachrichten zu Leclanche (Leclanché SA)
|
15:58 |
Gute Stimmung in Zürich: So steht der SPI am Mittwochnachmittag (finanzen.ch) | |
|
12:26 |
Mittwochshandel in Zürich: SPI notiert im Plus (finanzen.ch) | |
|
10:02 |
SPI-Papier Leclanche (Leclanché SA)-Aktie: So viel Verlust hätte ein Leclanche (Leclanché SA)-Investment von vor 10 Jahren eingebracht (finanzen.ch) | |
|
09:28 |
Börse Zürich: SPI-Anleger greifen zum Start des Mittwochshandels zu (finanzen.ch) | |
|
07:00 |
Leclanché ernennt Jens Emrich zum Chief Financial Officer (EQS Group) | |
|
07:00 |
Leclanché Appoints Jens Emrich as Chief Financial Officer (EQS Group) | |
|
24.02.26 |
Börse Zürich: SPI beendet den Dienstagshandel in der Gewinnzone (finanzen.ch) | |
|
24.02.26 |
Freundlicher Handel in Zürich: SPI auf grünem Terrain (finanzen.ch) |
Analysen zu Leclanche (Leclanché SA)
Longevity = mehr Rendite? Dr. Anna Erat über Healthspan & Investments – zu Gast im BX Morningcall
Im neuesten BX Morningcall ist Dr. Anna Erat zu Gast – Spezialistin für Innere Medizin, Sportmedizin, Prävention und Longevity. Gemeinsam mit Olivia Hähnel und François Bloch sprechen wir darüber, was Longevity wirklich bedeutet (Healthspan vs. Lifespan), warum es mehr ist als Biohacking und wie man seriöse Angebote von Hype unterscheidet.
Dr. Erat gibt Einblick, wie eine erste Longevity-Konsultation abläuft, welche Rolle Anamnese, Genetik/Epigenetik und Technologie/AI spielen und worauf Patientinnen und Patienten bei der Wahl eines Anbieters achten sollten. Ausserdem: Versicherung & Kostenübernahme in der Schweiz, Erwartungsdruck bei High-Performance-Klienten und ein spannender Case: Wie würde sie mit Lindsey Vonn nach einer Verletzung umgehen?
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Heimische Zahlenflut und anstehende NVIDIA-Bilanz: SMI etwas tiefer -- DAX überspringt 25'000 Punkte -- US-Börsen fester -- KI-Hoffnungen trieben Asiens Börsen - Nikkei mit RekordSMI-Anleger halten zur Wochenmitte die Füsse still. Am deutschen Aktienmarkt sind unterdessen moderate Gewinne zu sehen. Die Wall Street notiert in Grün. An den Börsen in Asien dominierten am Mittwoch die Bullen.


